Skip to main content

Moderna Helps, but It’s not this ETFs Only Catalyst

By: ETFdb
Moderna ( MRNA ) is one of the biggest stories in the biotechnology space this year because the company is one of the leading contenders to bring a coronavirus vaccine to market. To that point, Moderna stock soared Monday on news that its Covid-19 vaccine is making progress faster than many expected.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.